A detailed history of Venture Visionary Partners LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Venture Visionary Partners LLC holds 10,375 shares of ESPR stock, worth $22,098. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,375
Previous 10,375 -0.0%
Holding current value
$22,098
Previous $23,000 26.09%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$2.02 - $3.02 $20,957 - $31,332
10,375 New
10,375 $27,000
Q2 2022

Jul 26, 2022

BUY
$4.77 - $6.67 $37,349 - $52,226
7,830 New
7,830 $49,000

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $142M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Venture Visionary Partners LLC Portfolio

Follow Venture Visionary Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venture Visionary Partners LLC with notifications on news.